Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Meheus

Showing results (81-90 of 137) with videos related to

Pageof 14
Sort By:
Sexually Transmitted Infections|February 11, 2003
First, do not harm: also an issue in NAA assay diagnostics for chlamydial infectionV Verhoeven, M Ieven, A Meheus, et al.
Bruxelles Medical|March 1, 1972
[Use of tobacco as a risk factor in patients with ischemic cardiopathies. Study of prevalence in a selected population]A Meheus, W Eylenbosch, J Doumit, et al.
Archives Belges = Belgisch Archief|January 1, 1986
Age and immune response to hepatitis B vaccine in mentally handicappedJ Reniers, R Vranckx, G Heremans, et al.
American Journal of Ophthalmology|November 15, 1989
Treatment of adult gonococcal keratoconjunctivitis with oral norfloxacinP Kestelyn, J Bogaerts, A M Stevens, et al.
Vaccine|January 1, 1992
Heat stability of a recombinant DNA hepatitis B vaccineP Van Damme, M Cramm, A Safary, et al.
AIDS Research|January 1, 1986
AIDS in IndonesiaR Vranckx, A Alisjahbana, J Reniers, et al.
Genitourinary Medicine|June 1, 1987
Importance of chlamydial antibodies in acute salpingitis in central AfricaE Frost, M Collet, J Reniers, et al.
BMJ (Clinical Research Ed.)|June 12, 1993
Hepatitis A vaccination for health care workersP van Damme, M Cramm, J C van der Auwera, et al.
Vaccine|June 28, 2001
Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications?G François, M Kew, P Van Damme, et al.
Lancet (London, England)|July 19, 1997
Epidemics of syphilis in the Russian Federation: trends, origins, and priorities for controlL Tichonova, K Borisenko, H Ward, et al.
Pageof 14

Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
Sexually Transmitted Infections|February 11, 2003
First, do not harm: also an issue in NAA assay diagnostics for chlamydial infectionV Verhoeven, M Ieven, A Meheus, et al.
Bruxelles Medical|March 1, 1972
[Use of tobacco as a risk factor in patients with ischemic cardiopathies. Study of prevalence in a selected population]A Meheus, W Eylenbosch, J Doumit, et al.
Archives Belges = Belgisch Archief|January 1, 1986
Age and immune response to hepatitis B vaccine in mentally handicappedJ Reniers, R Vranckx, G Heremans, et al.
American Journal of Ophthalmology|November 15, 1989
Treatment of adult gonococcal keratoconjunctivitis with oral norfloxacinP Kestelyn, J Bogaerts, A M Stevens, et al.
Vaccine|January 1, 1992
Heat stability of a recombinant DNA hepatitis B vaccineP Van Damme, M Cramm, A Safary, et al.
AIDS Research|January 1, 1986
AIDS in IndonesiaR Vranckx, A Alisjahbana, J Reniers, et al.
Genitourinary Medicine|June 1, 1987
Importance of chlamydial antibodies in acute salpingitis in central AfricaE Frost, M Collet, J Reniers, et al.
BMJ (Clinical Research Ed.)|June 12, 1993
Hepatitis A vaccination for health care workersP van Damme, M Cramm, J C van der Auwera, et al.
Vaccine|June 28, 2001
Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications?G François, M Kew, P Van Damme, et al.
Lancet (London, England)|July 19, 1997
Epidemics of syphilis in the Russian Federation: trends, origins, and priorities for controlL Tichonova, K Borisenko, H Ward, et al.
Pageof 14